Novo Nordisk has multiple, strong upcoming, positive catalysts, related to its GLP-1 weight-loss drugs, Ozempic and Wegovy.

Founded in 1993, The Motley Fool is a financial services company dedicated to making the world smarter, happier, and richer.

If you buy through links on this page, we may earn a small commission. Here’s our process. Wegovy is a weight loss medication that you can only get with a prescription from a licensed healthcare ...

The release of OpenAI‘s ChatGPT chatbot in November 2022 unleashed a frenzy of investor interest in artificial intelligence ...

Some of the best opportunities can still be found in obesity treatment stocks. Look at Viking Therapeutics (NASDAQ:VKTX), for ...

We recently compiled a list of the 12 Best Biotech Stocks To Invest In According To Hedge Funds. In this article, we are ...

Here’s our process. We break down how to buy Wegovy online based on consultation, follow-up care, and cost. We first vetted the platforms for medical credibility and good business practices.

If you buy through links on this page, we may earn a small commission. Here’s our process. Wegovy is just one of the popular weight loss injections experiencing shortages. Due to increased ...

Amgen is a decently valued stock that has an excellent business and also gives investors a way to potentially gain exposure to a lucrative weight loss market.

GLP-1 supplements are advertised as a cheaper alternative to weight loss with Ozempic or Wegovy. Doctors explain if they help ...

Discover whether you should invest in these three stocks before the U.S. presidential election, analyzing potential impacts on the market and your portfolio.

Viking Therapeutics Inc. (NASDAQ: VKTX), a clinical-stage biotechnology company with a market cap approaching $7 billion, is ...